Semaglutide is a widely discussed medication primarily used for managing type 2 diabetes and chronic weight. As a GLP-1 receptor agonist, it helps regulate...
Semaglutide is primarily prescribed for adults with type 2 diabetes to improve blood sugar control. It is also approved for chronic weight management in adults who are obese or overweight with at least one weight-related comorbidity.
Semaglutide mimics the GLP-1 hormone, which helps the pancreas release more insulin when blood sugar levels are high, reduces the amount of sugar made by the liver, and slows digestion. This process leads to better blood sugar control and increased feelings of fullness, aiding in weight loss.
Semaglutide is marketed under various brand names, including Ozempic® (for type 2 diabetes, injectable), Rybelsus® (for type 2 diabetes, oral), and Wegovy® (for chronic weight management, injectable).
Common side effects often include gastrointestinal issues such as nausea, vomiting, diarrhea, constipation, and abdominal pain. These side effects are typically mild to moderate and may decrease over time as the body adjusts to the medication.